Apology for the publication of Sheng et al. (2024).

Recently, published Sheng et al.'s (see record 2024-72017-001) article titled "The Development of Tibetan Children's Racial Bias in Empathy: The Mediating Role of Ethnic Identity and Wrongfulness of Ethnic Intergroup Bias." The article went through the standard peer review process.

Validation of a diet-induced Macaca fascicularis model of non-alcoholic steatohepatitis with dietary and pioglitazone interventions.

Aim: To develop an obese, insulin-resistant cynomolgus monkey model of non-alcoholic steatohepatitis (NASH) with fibrosis with a high fat/high cholesterol (HFHC) diet (with or without high fructose) and test its responsiveness to caloric restriction or pioglitazone.

Methods: First, two groups of monkeys (n = 24/group) with histologically proven NASH and fibrosis were fed the HFHC diet for 17 weeks. The treatment group was subjected to a 40% caloric restriction (CR) and had their diet switched from the HFHC diet to a chow diet (DSCR).

Nanocellulose-Based Conductive Membranes for Free-Standing Supercapacitors: A Review.

There is currently strong demand for the development of advanced energy storage devices with inexpensive, flexibility, lightweight, and eco-friendly materials. Cellulose is considered as a suitable material that has the potential to meet the requirements of the advanced energy storage devices. Specifically, nanocellulose has been shown to be an environmentally friendly material that has low density and high specific strength, Young's modulus, and surface-to-volume ratio compared to synthetic materials.

Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial.

Background: In models of dopaminergic neuronal loss, the dopamine agonist pramipexole has exhibited neuroprotective properties. The Pramipexole On Underlying Disease (PROUD) study was designed to identify whether early versus delayed pramipexole initiation has clinical and neuroimaging benefits in patients with Parkinson's disease (PD).

Methods: Between May 24, 2006, and April 22, 2009, at 98 centres, we recruited patients with PD diagnosed within 2 years and aged 30-79 years.